Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.40
Bid: 138.00
Ask: 138.40
Change: -2.80 (-2.00%)
Spread: 0.40 (0.29%)
Open: 140.00
High: 140.20
Low: 137.40
Prev. Close: 140.20
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

10 Nov 2015 11:48

RNS Number : 1852F
Kier Group PLC
10 November 2015
 

 

TR-1: Notifications of Major Interests in Shares

 

1: Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Kier Group plc

 

2: Reason for notification (yes/no)

An acquisition or disposal of voting rights

yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

no

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

no

An event changing the breakdown of voting rights

no

Other (please specify):

 

no

 

3. Full name of person(s) subject to the notification

obligation:

Standard Life Investments (Holdings) Limited (Parent Company) -10.114% comprised of:

Standard Life Investments Limited - 10.034%

Ignis Investment Services Limited - 0.08%

4. Full name of shareholder(s) (if different from 3.):

 Vidacos Nominees\HSBC

5. Date of the transaction (and date on which the threshold

is crossed or reached):

06/11/2015

6. Date on which issuer notified:

09/11/2015

7. Threshold(s) that is/are crossed or reached:

10%

 

 

8: Notified Details
A: Voting rights attached to shares
Class/type of share If possible use ISIN code
GB0004915632
 
Situation previous to the triggering transaction
Number of shares
Number of voting rights
9,550,615
9,550,615
 
Resulting situation after the triggering transaction
Number of shares
Number of voting rights
Percentage ofvoting rights
Direct
Indirect
Direct
Indirect
9,673,132
5,001,686
4,671,446
5.23
4.885
 

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Expiration date
Exercise/ conversion period/date
No. of voting rights that may be acquired(if the instrument exercised/converted)
Percentage of voting rights
 
 
 
 
 
 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

9,673,132

10.114

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Standard Life Investments (Holdings) Limited (Parent Company) -10.114% comprised of:

Standard Life Investments Limited - 10.034%

Ignis Investment Services Limited - 0.08%

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

Beth Melges, Deputy Company Secretary

Kier Group plc

15. Contact telephone number:

 

01767 640111

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFBLFFEFFBFBV
Date   Source Headline
13th Jan 20219:04 amRNSBlock listing Interim Review
21st Dec 202012:32 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
17th Dec 202010:53 amRNSResult of AGM
17th Dec 20207:00 amRNS2020 Annual General Meeting
24th Nov 202010:19 amRNSHolding(s) in Company
19th Nov 20202:06 pmRNSDirector/PDMR Shareholding
27th Oct 20209:40 amRNSDirector/PDMR Shareholding
26th Oct 20209:08 amRNSDirector/PDMR Shareholding
16th Oct 20201:30 pmRNSNotice of AGM
9th Oct 20201:30 pmRNSAnnual Financial Report
6th Oct 20209:07 amRNSHolding(s) in Company
30th Sep 20208:00 amRNSDirector/PDMR Shareholding
21st Sep 202011:44 amRNSDirector/PDMR Shareholding
18th Sep 20202:47 pmRNSHolding(s) in Company
17th Sep 20209:39 amRNSResults for the year ended 30 June 2020
17th Sep 20208:06 amRNSPublication of Full Year Results
7th Sep 20207:00 amRNSBoard Appointment
19th Aug 202010:18 amRNSDirector/PDMR Shareholding
7th Aug 20203:00 pmRNSDirector Declaration
5th Aug 20204:00 pmRNSHolding(s) in Company
5th Aug 20203:00 pmRNSHolding(s) in Company
23rd Jul 20209:34 amRNSHolding(s) in Company
22nd Jul 20209:30 amRNSHolding(s) in Company
21st Jul 202012:01 pmRNSDirector/PDMR Shareholding
9th Jul 20209:29 amRNSHolding(s) in Company
8th Jul 20209:15 amRNSHolding(s) in Company
1st Jul 20209:10 amRNSBlock listing Interim Review
1st Jul 20207:00 amRNSTrading update
22nd Jun 202010:01 amRNSDirector/PDMR Shareholding
8th Jun 20204:36 pmRNSHolding(s) in Company
5th Jun 20209:30 amRNSHolding(s) in Company
2nd Jun 202010:23 amRNSHolding(s) in Company
2nd Jun 20209:38 amRNSNotification of Change in Director’s Details
26th May 20208:51 amRNSHolding(s) in Company
22nd May 20209:17 amRNSHolding(s) in Company
22nd May 20207:00 amRNSBoard Change
19th May 20209:03 amRNSDirector/PDMR Shareholding
13th May 20209:28 amRNSHolding(s) in Company
7th May 20205:13 pmRNSHolding(s) in Company
22nd Apr 202012:00 pmRNSDirector/PDMR Shareholding
21st Apr 202010:01 amRNSHolding(s) in Company
17th Apr 20203:18 pmRNSHolding(s) in Company
1st Apr 202012:08 pmRNSSecond Price Monitoring Extn
1st Apr 202012:03 pmRNSPrice Monitoring Extension
31st Mar 20202:34 pmRNSNotification of Change of Director's Details
30th Mar 20207:01 amRNSBoard Changes
30th Mar 20207:00 amRNSCOVID-19 Update
25th Mar 202012:32 pmRNSHolding(s) in Company
20th Mar 20209:44 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.